Coca-Cola reported a fourth-quarter net income of $1.46 billion, or 34 cents per share, down from $2.04 billion, or 47 cents per share, a year earlier, as fresh pandemic curbs globally closed its biggest sales drivers, such as restaurants, cinemas, and sporting events.
In response, the company accelerated its workforce restructuring and slimmed down its portfolio.
Excluding restructuring charges and other items, Coke earned 47 cents per share, topping the 42 cents per share expected by analysts surveyed by Refinitiv.
Net sales dropped 5 percent to $8.6 billion, which was below last year's $9.07 billion. It was also short of analysts' expectations of $8.63 billion.
Organic revenue, which excludes the impact of foreign currency, acquisitions, or divestitures, dropped 3 percent in the quarter.
Unit case volume, a key demand indicator, plunged fell 3 percent, improving from a compared with a 4 percent drop in the preceding quarter.
All four of Coke's beverage segments reported volume declines, with Latin America being the only geographic region to report volume growth.


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Australian Household Spending Dips in December as RBA Tightens Policy
U.S. Condemns China's Dominance in Global Shipbuilding and Maritime Sectors
Bitcoin Hits $100K Milestone Amid Optimism Over Trump Policies
U.S. Stock Futures Rise as Markets Brace for Jobs and Inflation Data
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Apple Downgraded by Jefferies Amid Weak iPhone Sales and AI Concerns
Elliott Investment Management Takes Significant Stake in BP to Push for Value Growth
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Samsung Electronics Shares Jump on HBM4 Mass Production Report
U.S. Stock Futures Rise as Trump Takes Office, Corporate Earnings Awaited 



